{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:08:09Z","timestamp":1747166889315,"version":"3.40.5"},"reference-count":65,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.lpm.2015.02.023","type":"journal-article","created":{"date-parts":[[2015,8,5]],"date-time":"2015-08-05T22:24:32Z","timestamp":1438813472000},"page":"889-897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Maladies neurom\u00e9taboliques traitables associ\u00e9es aux troubles du spectre de la schizophr\u00e9nie"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0005-4765","authenticated-orcid":false,"given":"Olivier","family":"Bonnot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Kuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2015.02.023_bib0330","series-title":"Neurology and clinical neuroscience","first-page":"223","article-title":"Schizophrenia and schizophrenia-like psychosis","author":"Price","year":"2003"},{"issue":"2","key":"10.1016\/j.lpm.2015.02.023_bib0335","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1017\/S0033291700024922","article-title":"The occurrence of organic disease of possible or probable aetiological significance in a population of 268\u00a0cases of first episode schizophrenia","volume":"17","author":"Johnstone","year":"1987","journal-title":"Psychol Med"},{"issue":"1","key":"10.1016\/j.lpm.2015.02.023_bib0340","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1542\/peds.105.1.e10","article-title":"Incidence of inborn errors of metabolism in British Columbia, 1969\u20131996","volume":"105","author":"Applegarth","year":"2000","journal-title":"Pediatrics"},{"issue":"65","key":"10.1016\/j.lpm.2015.02.023_bib0345","first-page":"1","article-title":"Diagnostic and treatment implications of psychosis secondary to treatable metabolice disorders in adults: a systematic review","volume":"9","author":"Bonnot","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.lpm.2015.02.023_bib0350","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/ajmg.1320260427","article-title":"Psychiatric manifestations of homocystinuria due to cystathionine beta-synthase deficiency: prevalence, natural history, and relationship to neurologic impairment and vitamin B6-responsiveness","volume":"26","author":"Abbott","year":"1987","journal-title":"Am J Med Genet"},{"issue":"3","key":"10.1016\/j.lpm.2015.02.023_bib0355","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/003130299105025","article-title":"Homocystinuria and psychiatric disorder: a case report","volume":"31","author":"Li","year":"1999","journal-title":"Pathology"},{"issue":"1","key":"10.1016\/j.lpm.2015.02.023_bib0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/aje\/kwj347","article-title":"Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review","volume":"165","author":"Gilbody","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.lpm.2015.02.023_bib0365","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-2236(03)00032-8","article-title":"Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders","volume":"26","author":"Mattson","year":"2003","journal-title":"Trends Neurosci"},{"issue":"10","key":"10.1016\/j.lpm.2015.02.023_bib0370","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/archneur.60.10.1457","article-title":"Neuropsychiatric disturbances in presumed late-onset cobalamin C disease","volume":"60","author":"Roze","year":"2003","journal-title":"Arch Neurol"},{"issue":"23","key":"10.1016\/j.lpm.2015.02.023_bib0375","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1056\/NEJM199006073222307","article-title":"Hyperammonemia in women with a mutation at the ornithine carbamoyltransferase locus. A cause of postpartum coma","volume":"322","author":"Arn","year":"1990","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.lpm.2015.02.023_bib0380","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00431-003-1188-9","article-title":"Outcome and survival of 88\u00a0patients with urea cycle disorders: a retrospective evaluation","volume":"162","author":"Bachmann","year":"2003","journal-title":"Eur J Pediatr"},{"issue":"5\u00a0Pt 2","key":"10.1016\/j.lpm.2015.02.023_bib0385","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1097\/01.AOG.0000157769.90230.24","article-title":"Postpartum \u201cpsychosis\u201d in mild argininosuccinate synthetase deficiency","volume":"105","author":"Enns","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.lpm.2015.02.023_bib0390","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1203\/PDR.0b013e3181a27a16","article-title":"Intellectual, adaptive, and behavioral functioning in children with urea cycle disorders","volume":"66","author":"Krivitzky","year":"2009","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1016\/j.lpm.2015.02.023_bib0395","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00003246-200201000-00035","article-title":"Late diagnosis of ornithine transcarbamylase defect in three related female patients: polymorphic presentations","volume":"30","author":"Legras","year":"2002","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.lpm.2015.02.023_bib0400","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0735-6757(96)90097-2","article-title":"Vomiting, ataxia, and altered mental status in an adolescent: late-onset ornithine transcarbamylase deficiency","volume":"14","author":"Myers","year":"1996","journal-title":"Am J Emerg Med"},{"issue":"10","key":"10.1016\/j.lpm.2015.02.023_bib0405","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1007\/s00134-008-1217-2","article-title":"Acute hyperammonemic encephalopathy in adult onset ornithine transcarbamylase deficiency","volume":"34","author":"Panlaqui","year":"2008","journal-title":"Intensive Care Med"},{"issue":"Pt 3","key":"10.1016\/j.lpm.2015.02.023_bib0410","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1258\/acb.2010.009250","article-title":"Fatal ammonia toxicity in an adult due to an undiagnosed urea cycle defect: under-recognition of ornithine transcarbamylase deficiency","volume":"47","author":"Thurlow","year":"2010","journal-title":"Ann Clin Biochem"},{"issue":"2","key":"10.1016\/j.lpm.2015.02.023_bib0415","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-2008-1040701","article-title":"Neurologic manifestations of acute porphyria","volume":"2","author":"Bonkowsky","year":"1982","journal-title":"Semin Liver Dis"},{"issue":"4","key":"10.1016\/j.lpm.2015.02.023_bib0420","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/00004583-198907000-00022","article-title":"Acute intermittent porphyria in a children's psychiatric hospital","volume":"28","author":"Boon","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"182","key":"10.1016\/j.lpm.2015.02.023_bib0425","first-page":"229","article-title":"Hereditary coproporphyria. Demonstration of the abnormalities in haem biosynthesis in peripheral blood","volume":"46","author":"Brodie","year":"1977","journal-title":"Q J Med"},{"issue":"7168","key":"10.1016\/j.lpm.2015.02.023_bib0430","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0140-6736(61)92169-9","article-title":"Psychiatric aspects of acute porphyria","volume":"1","author":"Cashman","year":"1961","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.lpm.2015.02.023_bib0435","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/jnnp.62.4.319","article-title":"The little imitator--porphyria: a neuropsychiatric disorder","volume":"62","author":"Crimlisk","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"110","key":"10.1016\/j.lpm.2015.02.023_bib0440","first-page":"183","article-title":"Acute intermittent porphyria: a study of 50\u00a0cases","volume":"28","author":"Goldberg","year":"1959","journal-title":"Q J Med"},{"issue":"4","key":"10.1016\/j.lpm.2015.02.023_bib0445","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1023\/A:1016598207397","article-title":"A molecular, enzymatic and clinical study in a family with hereditary coproporphyria","volume":"25","author":"Gross","year":"2002","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"10.1016\/j.lpm.2015.02.023_bib0450","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0009-9120(00)00159-4","article-title":"Hereditary coproporphyria in Germany: clinical-biochemical studies in 53\u00a0patients","volume":"33","author":"Kuhnel","year":"2000","journal-title":"Clin Biochem"},{"issue":"2","key":"10.1016\/j.lpm.2015.02.023_bib0455","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00005053-199402000-00012","article-title":"Psychiatric manifestations of hereditary coproporphyria in a child","volume":"182","author":"Mandoki","year":"1994","journal-title":"J Nerv Ment Dis"},{"issue":"11","key":"10.1016\/j.lpm.2015.02.023_bib0460","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/0006-3223(94)90085-X","article-title":"Varied psychiatric manifestations of acute intermittent porphyria","volume":"36","author":"Santosh","year":"1994","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.lpm.2015.02.023_bib0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197001000-00001","article-title":"Acute intermittent porphyria. A clinical and biochemical study of 46\u00a0patients","volume":"49","author":"Stein","year":"1970","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.lpm.2015.02.023_bib0470","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1176\/ajp.142.12.1430","article-title":"High prevalence of intermittent acute porphyria in a psychiatric patient population","volume":"142","author":"Tishler","year":"1985","journal-title":"Am J Psychiatry"},{"issue":"20","key":"10.1016\/j.lpm.2015.02.023_bib0475","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/0006-2952(75)90415-3","article-title":"Aggregation of blood platelets by adrenaline and its uptake","volume":"24","author":"Barthel","year":"1975","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.lpm.2015.02.023_bib0480","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2190\/BAFK-D0A7-Q1C4-V667","article-title":"The neuropsychiatry of Wilson's disease: a review","volume":"21","author":"Dening","year":"1991","journal-title":"Int J Psychiatry Med"},{"issue":"2","key":"10.1016\/j.lpm.2015.02.023_bib0485","article-title":"[Psychiatric manifestations in Wilson's disease]","volume":"124","author":"Schwartz","year":"1993","journal-title":"Harefuah"},{"issue":"12","key":"10.1016\/j.lpm.2015.02.023_bib0490","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1001\/archpsyc.1989.01810120068011","article-title":"Wilson's disease. Psychiatric symptoms in 195\u00a0cases","volume":"46","author":"Dening","year":"1989","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"10.1016\/j.lpm.2015.02.023_bib0495","first-page":"1436","article-title":"Pharmacological properties of new neuroleptic compounds","volume":"25","author":"Coscia","year":"1975","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.lpm.2015.02.023_bib0500","first-page":"171","article-title":"Psychiatric and behavioral abnormalities in Wilson's disease","volume":"65","author":"Akil","year":"1995","journal-title":"Adv Neurol"},{"issue":"4","key":"10.1016\/j.lpm.2015.02.023_bib0505","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1176\/jnp.3.4.377","article-title":"The psychiatric presentations of Wilson's disease","volume":"3","author":"Akil","year":"1991","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"3","key":"10.1016\/j.lpm.2015.02.023_bib0510","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0006-3223(90)90581-L","article-title":"Wilson's disease: a longitudinal study of psychiatric symptoms","volume":"28","author":"Dening","year":"1990","journal-title":"Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.lpm.2015.02.023_bib0515","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1176\/ajp.146.5.662","article-title":"Psychopathology in patients with Wilson's disease","volume":"146","author":"Medalia","year":"1989","journal-title":"Am J Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.lpm.2015.02.023_bib0520","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jns.2007.09.009","article-title":"Dominant psychiatric manifestations in Wilson's disease: a diagnostic and therapeutic challenge!","volume":"266","author":"Srinivas","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.lpm.2015.02.023_bib0525","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1192\/bjp.147.6.677","article-title":"Psychiatric aspects of Wilson's disease","volume":"147","author":"Dening","year":"1985","journal-title":"Br J Psychiatry"},{"issue":"18","key":"10.1016\/j.lpm.2015.02.023_bib0530","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/0006-2952(75)90018-0","article-title":"Effects of 5,6-dihydroxytryptamine on tyrosine-hydroxylase activity in central catecholaminergic neurons of the rat","volume":"24","author":"Renaud","year":"1975","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.lpm.2015.02.023_bib0535","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/MD.0b013e318045a00e","article-title":"Wilson disease: description of 282\u00a0patients evaluated over 3\u00a0decades","volume":"86","author":"Taly","year":"2007","journal-title":"Medicine"},{"issue":"10","key":"10.1016\/j.lpm.2015.02.023_bib0540","first-page":"899","article-title":"[Wilson's disease associated with olfactory paranoid syndrome and idiopathic thrombocytopenic purpura]","volume":"55","author":"Sagawa","year":"2003","journal-title":"No To Shinkei"},{"issue":"6","key":"10.1016\/j.lpm.2015.02.023_bib0545","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.genhosppsych.2008.05.005","article-title":"Delusional disorder and alcohol abuse in a patient with Wilson's disease","volume":"30","author":"Spyridi","year":"2008","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.lpm.2015.02.023_bib0550","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1046\/j.1440-1819.2002.01071.x","article-title":"Wilson's disease in psychiatric patients","volume":"56","author":"Stiller","year":"2008","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.lpm.2015.02.023_bib0555","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1440-1819.2006.01592.x","article-title":"Wilson's disease asociated with delusional disorder","volume":"60","author":"Wichowicz","year":"2006","journal-title":"Psychiatry Clin Neurosci"},{"issue":"10","key":"10.1016\/j.lpm.2015.02.023_bib0560","first-page":"963","article-title":"The inadvisability of neuroleptic medication in Wilson's disease","volume":"16","author":"Tu","year":"1981","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.lpm.2015.02.023_bib0565","first-page":"278","article-title":"Wilson's disease, psychosis, and ECT","volume":"13","author":"Shah","year":"1997","journal-title":"Convuls Ther"},{"key":"10.1016\/j.lpm.2015.02.023_bib0570","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-5-16","article-title":"Niemann-Pick disease type C","volume":"5","author":"Vanier","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"10.1016\/j.lpm.2015.02.023_bib0575","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","article-title":"Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study","volume":"6","author":"Patterson","year":"2007","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.lpm.2015.02.023_bib0580","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.neurenf.2011.04.004","article-title":"Pourquoi s\u2019int\u00e9resser \u00e0 la maladie de Niemann Pick de type C quand on est psychiatre d\u2019enfant et d\u2019adolescent\u00a0?","volume":"59","author":"Bonnot","year":"2011","journal-title":"Neuropsychiatr Enfance Adolesc"},{"issue":"9","key":"10.1016\/j.lpm.2015.02.023_bib0585","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00787-009-0010-2","article-title":"Niemann-Pick disease type C1\u00a0presenting with psychosis in an adolescent male","volume":"18","author":"Sandu","year":"2009","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"1","key":"10.1016\/j.lpm.2015.02.023_bib0590","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s10545-006-0417-6","article-title":"Neuropsychological profile of adult patients with Niemann-Pick C1 (NPC1) mutations","volume":"30","author":"Klarner","year":"2007","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"10.1016\/j.lpm.2015.02.023_bib0595","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1017\/S1092852900000067","article-title":"Cerebrotendinous xanthomatosis presenting with severe externalized disorder: improvement after one year of treatment with chenodeoxycholic acid","volume":"15","author":"Bonnot","year":"2010","journal-title":"CNS Spectr"},{"key":"10.1016\/j.lpm.2015.02.023_bib0600","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1038\/tp.2013.76","article-title":"Psychiatric manifestations in cerebrotendinous xanthomatosis","volume":"3","author":"Fraidakis","year":"2013","journal-title":"Transl Psychiatry"},{"issue":"1","key":"10.1016\/j.lpm.2015.02.023_bib0605","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000338548","article-title":"Early-onset schizophrenia","volume":"66","author":"Remschmidt","year":"2012","journal-title":"Neuropsychobiology"},{"issue":"2\u20133","key":"10.1016\/j.lpm.2015.02.023_bib0610","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.schres.2009.04.021","article-title":"Association of adolescent catatonia with increased mortality and morbidity: evidence from a prospective follow-up study","volume":"113","author":"Cornic","year":"2009","journal-title":"Schizophr Res"},{"issue":"1\u20133","key":"10.1016\/j.lpm.2015.02.023_bib0615","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.schres.2007.09.025","article-title":"Prevalence of 22q11.2\u00a0deletions in 311\u00a0Dutch patients with schizophrenia","volume":"98","author":"Hoogendoorn","year":"2008","journal-title":"Schizophr Res"},{"issue":"9","key":"10.1016\/j.lpm.2015.02.023_bib0620","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/01.chi.0000228131.56956.c1","article-title":"The 22q11.2\u00a0deletion in children: high rate of autistic disorders and early onset of psychotic symptoms","volume":"45","author":"Vorstman","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"11","key":"10.1016\/j.lpm.2015.02.023_bib0625","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00005053-200211000-00002","article-title":"Very late-onset schizophrenia-like psychosis: clinical and imaging characteristics in comparison with elderly patients with schizophrenia","volume":"190","author":"Barak","year":"2002","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.lpm.2015.02.023_bib0630","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1192\/bjp.151.3.324","article-title":"The phenomenology of acute organic psychosis. Comparison with acute schizophrenia","volume":"151","author":"Cutting","year":"1987","journal-title":"Br J Psychiatry"},{"issue":"2","key":"10.1016\/j.lpm.2015.02.023_bib0635","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1479-8301.2009.00282.x","article-title":"Pathogenesis and symptomatology of hallucinations (delusions) of organic brain disorder and schizophrenia","volume":"9","author":"Horiguchi","year":"2009","journal-title":"Psychogeriatrics"},{"issue":"3","key":"10.1016\/j.lpm.2015.02.023_bib0640","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/JCP.0b013e3182549259","article-title":"Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis","volume":"32","author":"Cohen","year":"2012","journal-title":"J Clin Psychopharmacol"},{"issue":"Suppl 14","key":"10.1016\/j.lpm.2015.02.023_bib0645","first-page":"4","article-title":"The costs of schizophrenia","volume":"68","author":"McEvoy","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.lpm.2015.02.023_bib0650","first-page":"1","article-title":"Schizophr\u00e9nies \u00e0 d\u00e9but pr\u00e9coce","volume":"10","author":"Dumas","year":"2013","journal-title":"EMC Psychiatrie"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498215002973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498215002973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T22:29:08Z","timestamp":1599431348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498215002973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":65,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0755498215002973"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2015.02.023","relation":{},"ISSN":["0755-4982"],"issn-type":[{"type":"print","value":"0755-4982"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maladies neurom\u00e9taboliques traitables associ\u00e9es aux troubles du spectre de la schizophr\u00e9nie","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2015.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}